MedPath

辽宁鑫善源药业有限公司

Ownership
-
Established
2003-03-28
Employees
-
Market Cap
-
Website
www.lnxsyyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

33

NMPA:33

Drug Approvals

Aspirin Enteuic-coated Tablets

Product Name
阿司匹林肠溶片
Approval Number
国药准字H20258021
Approval Date
Feb 24, 2025
NMPA

Acarbose Tablets

Product Name
阿卡波糖片
Approval Number
国药准字H20213661
Approval Date
Aug 25, 2021
NMPA

Acarbose Tablets

Product Name
阿卡波糖片
Approval Number
国药准字H20213662
Approval Date
Aug 25, 2021
NMPA

Trimetazidine Hydrochloride Tablets

Product Name
盐酸曲美他嗪片
Approval Number
国药准字H20213217
Approval Date
Mar 23, 2021
NMPA

Atorvastatin Calcium Tablets

Product Name
阿托伐他汀钙片
Approval Number
国药准字H20213068
Approval Date
Jan 30, 2021
NMPA

Atorvastatin Calcium Tablets

Product Name
阿托伐他汀钙片
Approval Number
国药准字H20213067
Approval Date
Jan 30, 2021
NMPA

Belladonna Sulfamethoxazole and Trimerhoprim Tablets

Product Name
颠茄磺苄啶片
Approval Number
国药准字H21022982
Approval Date
Jan 7, 2021
NMPA

Oxytetracycline Tablets

Product Name
土霉素片
Approval Number
国药准字H21020594
Approval Date
Jan 7, 2021
NMPA

Vitamin U,Aluminium Hydroxide and Magnesium Trisilicate Tablets

Product Name
维U颠茄铝镁片
Approval Number
国药准字H21023408
Approval Date
Jan 7, 2021
NMPA

Theophylline and Ephedrine Hydrochloride Tablets

Product Name
茶碱麻黄碱片
Approval Number
国药准字H21023949
Approval Date
Jan 7, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.